Telangana DCA conducts 65 seizures in March related to various offences: Peethaambaran Kunnathoor, Chennai Monday, April 21, 2025, 08:00 Hrs [IST] In the month of March, 2025, the ...

All these firms recorded higher growth rates compared to Indian Pharma Market. Among other outperformers were Sun Pharmaceutical Industries and Glenmark Pharmaceuticals. Sun Pharmaceuticals marked ...

Garfunkel, one half of Rock and Roll Hall of Fame duo Simon & Garfunkel, is speaking out for the first time about living with psoriasis in Sun Pharma’s I LUV YA for The Long Haul campaign, which aims ...

Sun Pharmaceutical Industries Ltd. closed 10.67% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Although Trump's pharma sector tariffs are threatening to hit the sector, and different estimates of the possible impact, analysts across brokerages are keeping their expectations steady for ...

Shares of major Indian pharmaceutical companies on Wednesday, including Aurobindo Pharma, Sun Pharmaceutical Industries (Sun Pharma), Zydus Lifesciences, Dr. Reddy's Laboratories, Gland Pharma and ...

Sun Pharmaceutical Industries, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1751.95. The stock has experienced fluctuations ...

Sun Pharma successfully removed an injunction in the US on the launch of its Leqselvi for alopecia areata, a common form of hair loss, that was sought by rival Incyte. The decision in the US Court ...

Sun Ten Pharmaceutical has established itself as a leading global manufacturer of high-quality herbal remedies by merging traditional Chinese medicine with modern pharmaceutical science. Now, it is ...

On Sunday, India-based Sun Pharmaceutical Industries Limited agreed to acquire U.S.-based immunotherapy and targeted oncology company Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) for an upfront ...

Sun Pharma has agreed a takeover deal with US biotech Checkpoint Therapeutics, which recently claimed FDA approval for its first drug but is also running low on cash. The Indian pharma group ...